Major Recall of Tylenol Products Leaves Shortage
By: Mike Zaman
Many of us remember the recent recall by Johnson & Johnson of several of its children’s medicines, including children and infant’s Tylenol and Motrin, and Benadryl. Approximately 135 million of these products were removed from stores shelves nationwide on April 30, 2010. What many probably did not realize is that supply of these medicines remains remarkably low…and will apparently remain that way through 2010 as announced by Johnson & Johnson Thursday.
The delay is largely due to Johnson & Johnson’s need to close its drug making division, McNeil Products, plant in Fort Washington, Pennsylvania after receiving a scathing inspection report from the Food & Drug Administration. The plant is not expected to reopen any time soon. Unfortunately for parents nationwide, the Fort Washington plant was responsible for making off of Johnson & Johnson’s medicine for children.
During this delay, parents will likely use generic versions of these medicines. The long-term effect on Johnson & Johnson’s bottom line is unknown, but it would be surprising if it didn’t take a major toll.
The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of this Web-Site or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company or person mentioned or referred to in the article.
Tags: benedryl, childrens medicine, infants, Johnson & Johnson, Mike Zaman, motrin, recall, shortage, Tylenol
